Epilepsy Pathway Innovation in Africa
Epilepsy affects over 50 million people across the world. 80% of these people live in low to middle income countries. There is a very high rate of epilepsy in Africa, where misunderstanding and stigma lead to limited diagnoses and treatment.
Epilepsy Pathway Innovation in Africa (EPINA) is a research team based in Oxford that has partnered with leading institutions in Kenya, Ghana and Tanzania. Working in these countries, EPINA aims to:
- better understand the impact of stigma on people with epilepsy
- improve epilepsy knowledge to improve help-seeking and treatment
- develop an app to help healthcare workers to diagnose epilepsy
- develop portable electroencephalograms to diagnose epilepsy in rural settings
- improve medication adherence through text messaging.
EPINA could dramatically change the lives of people with epilepsy in sub Saharan Africa. If successful, we will use our knowledge to ensure that similar work is carried out across other low and middle-income countries.
Visit the EPInA website here: https://epina.web.ox.ac.uk
Subscribe to the EPInA newsletter here: https://epina.web.ox.ac.uk/article/newsletters
Latest publications
-
Serological Markers of Clinical Improvement in MuSK Myasthenia Gravis
Journal article
Spagni G. et al, (2024), Neurology Neuroimmunology & Neuroinflammation, 11
-
Accelerated 3D multi‐channel B1+ mapping at 7 T for the brain and heart
Journal article
Kent JL. et al, (2024), Magnetic Resonance in Medicine, 92, 2007 - 2020
-
Internally-consistent and fully-unbiased multimodal MRI brain template construction from UK Biobank: Oxford-MM
Journal article
LANGE F. et al, (2024), Imaging Neuroscience
-
In vivo cartography of state-dependent signal flow hierarchy in the human cerebral cortex
Preprint
Hong S-J. et al, (2024)